About ALEMBIC LIMITED
ALEMBIC LIMITED is a Public Limited Company and was incorporated on Jul 30, 1907 in India. It is registered at Registrar of Companies, ROC Ahmedabad. Its registered address is ALEMBIC ROAD, BARODA, Gujarat, India, 390003. Its corporate identification number is (CIN) L26100GJ1907PLC000033 and its current status is Active. Its industry classification as per MCA is manufacture Of Glass And Glass Products. It had a team size of 274 employees as on Oct 31, 2024.
ALEMBIC LIMITED's last Annual General Meeting (AGM) was held on Aug 12, 2025 as per records from Ministry of Corporate Affairs (MCA). ALEMBIC LIMITED's authorised share capital is ₹60Cr and its paid up capital is ₹51.4Cr. The current board of directors of ALEMBIC LIMITED comprises Chirayu Ramanbhai Amin, Udit Chirayu Amin and 6 more.
ALEMBIC LIMITED generated between ₹100 Cr and ₹500 Cr in revenue for the financial year ending on Mar 31, 2026.
Key Metrics
CIN
L26100GJ1907PLC000033
Location
Current Status
Active
Entity Type
Public Limited Company
Date Of Incorporation
Jul 30, 1907
Company Age
119 Years 1 Month
Registrar of Companies
ROC - Ahmedabad
Last AGM Date
Aug 12, 2025
Latest Revenue
₹100 - ₹500 Cr as on Mar 31, 2026
Latest Employee Count
274 as on Oct 31, 2024
Authorized Capital
₹60Cr
Paid Up Capital
₹51.4Cr
Contact Details for ALEMBIC LIMITED
- *****@alembic.co.in, *****@alembic.co.in
- Registered Address
- ALEMBIC ROAD, BARODA, Gujarat, India, 390003
Brands associated with ALEMBIC LIMITED
There is one brand associated with ALEMBIC LIMITED which include Alembic .
Principal Business Activity of ALEMBIC LIMITED
The majority of ALEMBIC LIMITED's turnover comes from Real estate activities.
Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
L | Real estate activities | 68 | Real estate activities | ob{ |
C | Manufacturing | 20 | Manufacture of chemicals and chemical products | hvi |
Documents of ALEMBIC LIMITEDFY 25 Available15 mins
15 minsFiling Summary
Here is a summary of filing activity and document availability across financial years:
File Type | FY 24-25 | FY 23-24 | FY 22-23 | FY 21-22 | FY 20-21 |
|---|---|---|---|---|---|
Financial Statements | |||||
Annual Returns |
Latest Financials, Share Allotment and Annual Report
The latest filed financial documents, annual reports, and share allotment filings are shown below:
Recent Filings
Below are the most recent filings submitted by the company:
Document Name | Category | Filing Date |
|---|---|---|
Optional attachment(s)- if any | Annual Returns and Balance Sheet eForms | Oct 09, 2025 |
Optional attachment(s)- if any | Annual Returns and Balance Sheet eForms | Oct 09, 2025 |
List of share holders, debenture holders; | Annual Returns and Balance Sheet eForms | Oct 09, 2025 |
Details of shares_Debentures Transfers | Annual Returns and Balance Sheet eForms | Oct 09, 2025 |
Form MGT-7 | Annual Returns and Balance Sheet eForms | Oct 09, 2025 |
Photograph of the registered office of the Company showing external building and name prominently visible | Annual Returns and Balance Sheet eForms | Oct 09, 2025 |
Certified copy of the consent for holding general meeting on shorter notice under Section 101 read with Section 136 of the Companies Act, 2013 along with list of shareholders? of the Company (In case, the general meeting of the company was not held within clear twenty one day?s notice either in writing or through electronic mode in such manner as may be prescribed) | Change in Directors | Oct 01, 2025 |
Certified copy of the Shareholders? Resolution of the Company in favour of proposal along with notice and explanatory statement pursuant to Section 102 of the Act | Change in Directors | Oct 01, 2025 |
Copy of employment visa_ passport, in case the proposed appointee is a foreign citizen; | Change in Directors | Oct 01, 2025 |
Auditors Certificate pursuant to Section 164 (2) of the Companies Act, 2013 | Change in Directors | Oct 01, 2025 |
To access all company documents and filings with a single purchase, Buy Financials and Company Filings FY 25 Available15 mins
Financials of ALEMBIC LIMITEDFY 26 Available
ALEMBIC LIMITED generated between ₹100 Cr and ₹500 Cr in revenue for the financial year ending on Mar 31, 2026. The revenue of ALEMBIC LIMITED has a compounded annual growth rate (CAGR) of 5% in the last 1 year.
Financial Statement Summary
Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
Income Statement | |||||
Revenue | 5625 | 2017 | 4389 | 5782 | 3396 |
Total Sales | 7424 | 9546 | 9304 | 3707 | 2803 |
Total Expenses | 3836 | 8212 | 6470 | 3732 | 9939 |
Operating Expenses | 8299 | 3867 | 9812 | 6667 | 4840 |
Employee Expenses | 8106 | 2507 | 6942 | 7820 | 3046 |
Marketing Expenses | 1539 | 8803 | 8773 | 4454 | 3094 |
Operating Income (EBIT) | 6326 | 8295 | 9806 | 2824 | 9385 |
Interest Expenses | 5267 | 1880 | 3637 | 1018 | 9698 |
Expenses from other activities | 9543 | 5931 | 1375 | 8293 | 5146 |
EBITDA | 1693 | 8366 | 4179 | 6412 | 6627 |
Taxes | 9035 | 4365 | 4163 | 8492 | 6064 |
Net Profit | 6948 | 5768 | 7701 | 4531 | 8909 |
Balance Sheet | |||||
Assets | 8615 | 2458 | 5270 | 4435 | 1472 |
Cash Equivalent | 4393 | 4896 | 5342 | 8692 | 3356 |
Accounts Receivables | 1307 | 7299 | 4543 | 7935 | 5143 |
Inventory | 4946 | 9812 | 1153 | 4694 | 3865 |
Liabilities | 4462 | 1514 | 8992 | 5342 | 3485 |
Total Debt | 5780 | 9527 | 2177 | 1666 | 6783 |
Accounts Payable | 2758 | 6929 | 1564 | 2232 | 5470 |
Equities | 8342 | 1637 | 1804 | 2167 | 5514 |
Cashflow Statement | |||||
Cash from Operating activities | 9517 | 2788 | 3397 | 3108 | 9784 |
Cash from Investing activities | 9715 | 4828 | 2792 | 5682 | 9556 |
Net cash from Financing activities | 1551 | 6387 | 1252 | 9699 | 2911 |
Ratios
Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
Profitability Ratios | |||||
EBITDA Margin | 1339 | 2104 | 9396 | 9501 | 9793 |
EBIT Margin | 8599 | 1975 | 4470 | 7974 | 2091 |
Net Profit Margin | 5386 | 7674 | 2200 | 4452 | 4138 |
Return on Assets (ROA) | 1605 | 6841 | 1778 | 8395 | 6227 |
Return on Equity (ROE) | 9805 | 5774 | 4103 | 6546 | 7319 |
Return on Capital Employed | 9089 | 4963 | 9935 | 3913 | 5925 |
Return on Invested Capital | 3241 | 2595 | 7630 | 2629 | 8269 |
Efficiency Ratios | |||||
Asset Turnover | 8470 | 7457 | 4269 | 1198 | 3386 |
Receivables Turnover | 4392 | 3537 | 3045 | 7945 | 9213 |
Days Sales Outstanding | 2408 | 1728 | 5063 | 2285 | 4893 |
Inventory Turnover | 1635 | 8895 | 7956 | 1087 | 2212 |
Days Inventory Outstanding | 3186 | 4044 | 2287 | 4568 | 9815 |
Payables Turnover | 7921 | 8905 | 3900 | 9475 | 3995 |
Days Payables Outstanding | 1721 | 1934 | 9427 | 6978 | 3340 |
Liquidity Ratios | |||||
Current Ratio | 6167 | 9176 | 3743 | 5322 | 5729 |
Quick Ratio | 7646 | 7974 | 4936 | 1391 | 5295 |
Cash Ratio | 5232 | 6350 | 6006 | 3526 | 7327 |
Coverage Ratios | |||||
Cash Flow Coverage Ratio | 7927 | 3628 | 5053 | 2557 | 9279 |
Debt Ratios | |||||
Debt-to-Equity Ratio | 7841 | 4662 | 2296 | 9568 | 2104 |
Debt Ratio | 5179 | 3825 | 8197 | 8746 | 2854 |
Net Debt | 8677 | 6471 | 5240 | 1757 | 5535 |
Interest Coverage Ratio | 8173 | 2092 | 8266 | 7777 | 5118 |
Debt Service Coverage Ratio | 4493 | 9238 | 7681 | 5168 | 5661 |
Net Debt/EBITDA | 6623 | 6413 | 2795 | 3828 | 3354 |
Growth Ratios | |||||
Revenue Growth Rate (CAGR) | 3628 | 4507 | 1648 | 1617 | 2535 |
Earnings Growth Rate (CAGR) | 4456 | 2583 | 3787 | 4945 | 4123 |
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
Compounded Annual Growth Rate of ALEMBIC LIMITED
Revenue CAGR | Growth |
|---|---|
1 Year | 5% |
3 Year | 525 |
5 Year | 544 |
EBITDA CAGR | Growth |
|---|---|
1 Year | -3% |
3 Year | 139 |
5 Year | 368 |
MSME Payment Delays by ALEMBIC LIMITED
Loans and Charges on ALEMBIC LIMITED
ALEMBIC LIMITED
has taken 21 loans and
has issued 2 loans as a lender.
Here is a list of loans and charges on ALEMBIC LIMITED:
As a Borrower
Loan/ Charge ID | Lender Name | Loan Amount | Status | Creation Date | Closure Date |
|---|---|---|---|---|---|
100795632 | ₹31Cr | arwmlxy | Sep 22, 2023 | pfyujah | |
10180279 | ₹25Cr | btmucyf | Sep 25, 2009 | akfgkzp | |
10169711 | ₹25Cr | pd{ltue | Aug 11, 2009 | zszagqk | |
10066212 | ₹75Cr | hwoqqnk | Sep 13, 2007 | muxkvym | |
10050110 | - | ₹30L | mvgmieb | May 15, 2007 | cfypnev |
10045239 | ₹43Cr | bjl{kwd | Apr 05, 2007 | srzvlev | |
10045873 | ₹22.8Cr | kldptgl | Dec 15, 2006 | wobxkms | |
10004303 | - | ₹36Cr | ualzjyu | May 08, 2006 | xfhgmrx |
80051741 | - | ₹30Cr | ah{ddqw | Nov 09, 2004 | qhefgzd |
80056684 | - | ₹23.2Cr | jyigwqv | Sep 03, 2004 | qushxlm |
80012801 | - | ₹12Cr | cjikhkx | May 24, 2004 | loxytyx |
80039844 | - | ₹40Cr | pssmqxy | Dec 26, 2003 | pfgllbx |
80038912 | - | ₹18.2Cr | rorjtoc | Dec 09, 2003 | ulrcrgh |
80039848 | ₹9Cr | eotwdsn | May 08, 2003 | ezmt{wx | |
80012799 | ₹10Cr | dyywbhs | Jul 09, 2001 | guntbfw | |
80039846 | ₹22.5Cr | wo{jl{d | Sep 30, 2000 | d{ydqps | |
80039849 | ₹10.5Cr | vdmpopr | Mar 01, 1999 | wxhobvh | |
80004760 | - | ₹7Cr | nnhfqou | Mar 01, 1999 | fqliyys |
80039845 | ₹41.1Cr | dmbofgm | Nov 27, 1998 | mzb{xnp | |
80039850 | - | ₹12Cr | vufbnps | Oct 17, 1998 | xeqiwux |
To access detailed information on a company’s loans, borrowings, & registered charges, Buy Detailed Report
As a Lender
Loan/ Charge ID | Borrower Name | Loan Amount | Status | Creation Date | Closure Date |
|---|---|---|---|---|---|
100028299 | ₹5Cr | nrotnht | Apr 29, 2016 | vrenb{z | |
100022015 | ₹5Cr | kilxeph | Mar 29, 2016 | sclenjv |
To access detailed information on a company’s loans, borrowings, & registered charges, Buy Detailed Report
Credit Ratings of ALEMBIC LIMITED
GSTIN Details of ALEMBIC LIMITED
Board of Directors and Signatories of ALEMBIC LIMITED
Board of Directors of ALEMBIC LIMITED
Here is the list of current board of directors of ALEMBIC LIMITED:
Name | Designation | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Mar 31, 2011 | 15 Years 5 Months | |
Managing Director | Current | Feb 01, 2017 | 9 Years 7 Months | |
Managing Director | Current | Feb 01, 2017 | 9 Years 7 Months | |
Director | Current | Sep 27, 2019 | 6 Years 11 Months | |
Director | Current | Sep 04, 2023 | 3 Years | |
Director | Current | Feb 12, 2025 | 1 Year 7 Months | |
Director | Current | Feb 12, 2025 | 1 Year 7 Months | |
Director | Current | Feb 12, 2025 | 1 Year 7 Months |
To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report
Signatories of ALEMBIC LIMITED
Here is the list of current signatories of ALEMBIC LIMITED:
Name | Designation(s) | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Mar 31, 2011 | 15 Years 5 Months | |
CFO | Current | Aug 13, 2014 | 12 Years 1 Month | |
Managing Director | Current | Feb 01, 2017 | 9 Years 7 Months | |
Managing Director | Current | Feb 01, 2017 | 9 Years 7 Months | |
Director | Current | Sep 27, 2019 | 6 Years 11 Months | |
Director | Current | Sep 04, 2023 | 3 Years | |
Company Secretary | Current | Sep 04, 2023 | 3 Years | |
Director | Current | Feb 12, 2025 | 1 Year 7 Months | |
Director | Current | Feb 12, 2025 | 1 Year 7 Months | |
Director | Current | Feb 12, 2025 | 1 Year 7 Months |
To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report
Cross Directorships of ALEMBIC LIMITED
ALEMBIC LIMITED has directors who also hold positions in 16 other legal entities. All are listed below:
Legal Entity Name | % of Common Directors | Common Director(s) | Open Charge(s) | Active Legal Case(s) |
|---|---|---|---|---|
PAUSHAK LIMITED CIN: L51909GJ1972PLC044638, India, Active | 234 | 512 | 249 | 818 |
NIRAYU PRIVATE LIMITED CIN: U28100GJ1971PTC098778, India, Active | 721 | 609 | 384 | 549 |
SIERRA INVESTMENTS PRIVATE LIMITED (TR CO ) CIN: U70109GJ1988PTC044681, India, Amalgamated | 843 | 563 | 954 | 564 |
ELEVENTA PROPERTIES PRIVATE LIMITED CIN: U68100GJ2026PTC176196, India, Inactive for e-filing | 107 | 626 | 454 | 605 |
WHISPERING MIST ESTATE AND INFRA PRIVATE LIMITED CIN: U68100GJ2026PTC176190, India, Inactive for e-filing | 454 | 253 | 743 | 947 |
ALEMBIC PHARMACEUTICALS LIMITED CIN: L24230GJ2010PLC061123, India, Active | 159 | 824 | 411 | 980 |
SIERRA HEALTHCARE LIMITED CIN: U85110GJ2008PLC055328, India, Amalgamated | 356 | 121 | 933 | 951 |
QUICK FLIGHT LIMITED. CIN: U21098GJ2007PLC074270, India, Amalgamated | 485 | 373 | 288 | 217 |
RATNA NICO CHEM PVT LTD CIN: U24231GJ1986PTC009168, India, Active | 682 | 158 | 414 | 146 |
Shiva Pharmachem Limited CIN: U24231GJ1999PLC035615, India, Active | 919 | 792 | 415 | 869 |
AAVARAN LIMITED CIN: U24299GJ1970PLC001809, India, Amalgamated | 642 | 784 | 758 | 902 |
STERLING FERRO ALLOYS PVT LTD CIN: U27101GJ1990PTC013373, India, Active | 626 | 524 | 823 | 240 |
ELECON EPC PROJECTS LIMITED. CIN: U29219GJ1991PLC015379, India, Amalgamated | 159 | 166 | 438 | 583 |
ALEMBIC CITY LIMITED CIN: U70100GJ1994PLC021552, India, Active | 616 | 824 | 155 | 646 |
SHRENO LIMITED CIN: U26100GJ1944PLC000345, India, Active | 490 | 169 | 114 | 162 |
SUVID HOSPITALS PRIVATE LIMITED CIN: U85300GJ2022PTC130219, India, Active | 713 | 625 | 213 | 627 |
To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report
Legal Cases involving ALEMBIC LIMITED
Employee Count of ALEMBIC LIMITED
ALEMBIC LIMITED has an employee count of 274 as on Oct 31, 2024.
Date | Employee Count |
|---|---|
Oct 24 | 274 |
Sep 24 | 831 |
Aug 24 | 877 |
Jul 24 | 561 |
Jun 24 | 536 |
May 24 | 151 |
Apr 24 | 654 |
Trademarks of ALEMBIC LIMITED
Patents of ALEMBIC LIMITED
Competitors & Alternates of ALEMBIC LIMITED
Alembic is the only brand associated with ALEMBIC LIMITED, and here are its Top 10 competitors ranked by Tracxn score:
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AbbVie 2012, Chicago (United States), Public | Research-based biopharmaceutical company | $14.7B | 81/100 | |
2nd | Amgen 1980, Thousand Oaks (United States), Public | Developer of pharmaceutical products for treating multiple diseases | - | 81/100 | |
3rd | Gilead 1987, Foster City (United States), Acquired | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | - | 80/100 | |
4th |  Johnson & Johnson 1886, New Brunswick (United States), Public | Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products | - | 76/100 | |
5th | Lilly 1876, Indianapolis (United States), Public | Developer of traditional pharmaceutical medicines | - | 75/100 | |
6th |  AstraZeneca 1999, Cambridge (United Kingdom), Public | Developer of pharmaceutical medicines for oncology and various chronic diseases | - | 73/100 | |
7th | Novartis 1996, Basel (Switzerland), Acquired | R&D focused on manufacturing of drugs for multiple therapeutic areas | - | 71/100 | |
8th |  Roivant Sciences 2014, New York City (United States), Public | Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases | $1.3B | 70/100 | |
9th |  Roche 1896, Basel (Switzerland), Public | Developer of pharmaceuticals and diagnostics kits | - | 70/100 | |
10th | Genentech 1976, San Francisco (United States), Acquired | R&D company focused on manufacturing drugs for multiple therapeutic areas | $72.5M | 69/100 | |
63rd | Manufacturer of active pharmaceuticals ingredients | - | - | 54/100 |
To view the full list of competitors of Alembic, Buy Detailed Report
News related to ALEMBIC LIMITED
Media has covered brands linked with ALEMBIC LIMITED for a total of 3 events in the last 1 year, 1 of them has been about company updates and 1 about partnerships.
•
•
Alembic Technologies Secures $145M & Nvidia Supercomputer for AI Acceleration.SiliconAngle•Nov 13, 2025•Alembic, Prysm Capital, Accenture, Nvidia and 7 others
•
Alembic: Holistic Marketing Attribution Platform Company Raises $14 MillionPulse 2.0•Feb 16, 2024•Alembic, WndrCo, m]x[v Capital, Liquid 2 Ventures and 4 others
•
Alembic Pharma arm gets USFDA nod for generic topical gel for acne vulgarisMoneycontrol•Aug 08, 2022•Alembic
•
•
Pharma industry faces inflation-induced slowdown: Alembic Pharmaceutical CFOMoneycontrol•May 27, 2022•Alembic
•
Alembic arm receives final USFDA approval for generic fever blisters drugBusiness Standard•May 04, 2022•Alembic, ALEOR Dermaceuticals
•
Alembic Pharma reports consolidated PAT at Rs 35 cr in March qtrBusiness Standard•May 02, 2022•Alembic
•
Alembic Pharma's subsidiary bags USFDA final approval for Clobetasol Propionate FoamIndia Infoline•Apr 25, 2022•Alembic, ALEOR Dermaceuticals
•
Alembic acquires 100% stake in Aleor Dermaceuticals from JV partnerBusiness Standard•Mar 29, 2022•Alembic, ALEOR Dermaceuticals, Orbicular Pharmaceutical Technologies
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!FAQs about ALEMBIC LIMITED
Explore our recently published Legal Entities
